WCG acquires Clintrax Global to expedite negotiations
The acquisition will provide WIRB-Copernicus Group (WCG) with new tools to expedite clients’ clinical research contract and budget negotiations.
Archives for March 9, 2016
Sticking with tradition: clinical trial sites prefer paper records
According to a recent survey, the majority of clinical trial site staff prefers paper-based assessments over eCOA solutions.
Twitter for #ClinicalTrials recruitment? Researchers see the potential
With 320m monthly active users, Twitter could potentially serve as a new, unexploited resource to stimulate interest and enrollment in clinical trials.
HIV vaccine developer Theravectys says GMP suspension at Paris plant won't delay trial
Theravectys has outlined a 1-year plan to fix GMP deficiencies at its Paris facility and said the current manufacturing ban will not delay its clinical programmes.
Crown Bioscience acquires PreClinOmics, adds CVMD models to portfolio
Crown Bioscience has announced the acquisition of PreClinOmics, an in vivo preclinical company specializing in early research in cardiovascular and metabolic diseases (CVMD).
Lupin buys Gavis Pharmaceuticals and gains first US facility
Lupin acquired drug formulation developer Gavis Pharmaceuticals this week in a deal that gives it its first manufacturing site in the US.
Industry consortium aims to take the pain out of ICH Q3D compliance
With the first deadline for the ICH Q3D guideline on elemental impurities just a few weeks away, pharma companies are still facing some uncertainty about how to comply with the requirements.
I/O therapies boosting R&D funding & alliances, says Tufts
With more than 130 biotech and 20 pharmaceutical companies currently developing immuno-oncology (I/O) therapies, the global oncology market could reach $40bn by 2020, says Tufts.